Atlas Trials

Phase I Safety Study of Dendritic Cell Vaccine to Treat Patients With Hepatocellular Carcinoma

Clinical trial NCT01974661 · COMPLETED

Trial details

NCT number
NCT01974661
Sponsor
Mendus
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Hepatocellular Carcinoma
Start date
2013-10-01
Primary completion
2017-06-28
Enrollment
18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.